Grants
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional) (PAR-25-224)
Sponsor
National Institute on Aging
Due Date
Application due February 21, 2025. Letter of Intent due 30 days prior to the application due date.